Literature DB >> 1163674

High-output heart failure in the dog: systemic and intrarenal role of angiotensin II.

R H Freeman, J O Davis, W S Spielman, T E Lohmeier.   

Abstract

Dogs with experimental high-output heart failure (HOF) exhibit marked retention of salt and water secondary to hypersecretion of both renin and aldosterone. The present study was undertaken to evaluate the systemic and intrarenal arteriolar action of angiotensin II (AII) in dogs with HOF and to provide additional information about the role of AII in low-output states. The intravenous infusion of a specific AII antagonist, [Sar1, Ala8]AII (6 mug/kg min-1), into conscious dogs with HOF decreased the mean arterial pressure (AP) from 101 +/- 7 to 83 +/- 7 mmHg (P less than 0.01) after 45 min of infusion. Intrarenal arterial infusion of the AII antagonist (0.2 and 2.0 mug/kg min-1) into anesthetized dogs with HOF also decreased AP and produced a marked increase in renal blood flow (RBF) with no changes in either creatinine clearance or sodium excretion. Similar results were obtained during the intrarenal infusion of the antagonist into sodium-depleted dogs and dogs with thoracic vena caval constriction, but not in normal dogs. The data demonstrate an important role for AII in the regulation of AP and RBF in high- and low-output states.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1163674     DOI: 10.1152/ajplegacy.1975.229.2.474

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Control of renal and extrarenal salt and water excretion by plasma angiotensin II in the kelp gull (Larus dominicanus).

Authors:  D A Gray; T Erasmus
Journal:  J Comp Physiol B       Date:  1989       Impact factor: 2.200

2.  Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure.

Authors:  S K Mujais; F M Fouad; S C Textor; R C Tarazi; E L Bravo; N Hart; R W Gifford
Journal:  Br Heart J       Date:  1984-07

3.  Angiotensin antagonists with increased specificity for the renal vasculature.

Authors:  K J Taub; W J Caldicott; N K Hollenberg
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.